Neogen NEOG
NASDAQ NEOG
$11.95 +0.12 (+1.01%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neogen (NEOG) Cash from Financing Activities (2010 - 2026)

Neogen (NEOG) posted quarterly Cash from Financing Activities of -$300000.0 for Q2 2026, up 85.71% year-over-year from -$161538.5 in Q2 2025, and down 140.32% quarter-over-quarter from $744000.0 in Q1 2026.

Neogen (NEOG) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Neogen's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$300000.0 for Q2 2026.

  • In Q2 2026, Cash from Financing Activities rose 85.71% year-over-year to -$300000.0; the TTM figure through May 2026 stood at -$99.4 million (down 6112.5% YoY), while the FY2026 annual figure was -$99.4 million, down 6112.5% from the prior year.
  • Cash from Financing Activities for Q2 2026 stood at -$300000.0, down from $744000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $1.2 million in Q1 2024, with the low at -$99.4 million in Q3 2025.
  • The 5-year median for Cash from Financing Activities is -$199500.0 (2024), against an average of -$12.1 million.
  • The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities soared 124.49% in 2023, then plunged 10252.5% in 2025.
  • Neogen's Cash from Financing Activities stood at -$79.3 million in 2022, then jumped by 99.61% to -$310000.0 in 2023, then sank by 354.52% to -$1.4 million in 2024, then soared by 67.99% to -$451000.0 in 2025, then jumped by 33.48% to -$300000.0 in 2026.
  • Business Quant data shows NEOG's Cash from Financing Activities at -$300000.0 in Q2 2026, $744000.0 in Q1 2026, and -$451000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -3.52 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -95.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -410.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -300,000.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -607.30 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -236.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -1.34 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -213.50 Mn
10 Neogen 2.61 Bn 2.42 Bn 107.80 Mn -300,000.00

Historic Data

Download Data
DateValue
May 31, 2026 -300,000.00
May 31, 2026 -300,000.00
Feb 28, 2026 744,000.00
Feb 28, 2026 744,000.00
Nov 30, 2025 -451,000.00
Nov 30, 2025 -451,000.00
Aug 31, 2025 -99.39 Mn
Aug 31, 2025 -99.39 Mn
May 31, 2025 -2.10 Mn
May 31, 2025 -2.10 Mn
Feb 28, 2025 930,000.00
Feb 28, 2025 930,000.00
Nov 30, 2024 -1.41 Mn
Nov 30, 2024 -1.41 Mn
Aug 31, 2024 979,000.00
Aug 31, 2024 979,000.00
May 31, 2024 -81,000.00
May 31, 2024 -81,000.00
Feb 29, 2024 1.25 Mn
Feb 29, 2024 1.25 Mn